Fundz

Link Cell Therapies

South San Francisco, California, United States · Biotechnology, Health Care, Therapeutics · 23 employees

Link Cell Therapies is a biotechnology company focused on advancing CAR-T therapies for solid and liquid tumors. Founded by experts from Stanford University, Link utilizes proprietary logic-gating technologies to enhance the targeting of cancer cells while minimizing damage to healthy tissues. Their innovative approach aims to develop multiple impactful treatments for various types of cancer. Link

Funding history

  • Series series a — $60.0M — Dec 2025

Recent signals

  • Dec 15, 2025: Raised $60.0M in Series series a

See plans & pricing → Track Link Cell Therapies’s funding, hiring, and signals — with verified contacts — on Fundz.